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Propofol: a safe anaesthetic drug in experimental cardiac surgery in rabbits
ACKGROUND: Experimental surgery needs a pharmacological approach that can interfere with cardiac function.
CASE REPORT: In a animal model of regenerative medicine of myocardium we use an anaesthesiological  protocol that
included Propofol, a benzodiazepine (Midazolam) and an alpha-2 adrenergic agent. 
RESULTS: In a group of 15 rabbits undergoing cardiac surgery we reported 1 arrhythmic complication during stem cell
injection.
DISCUSSION: The functional cardio- respiratory depressor activity of Propofol was compensated by alpha-2 adrenergic
drugs, avoiding serious complications. We hypothesize that the functional cardio-respiratory depressor of different anaes-
thesiological drugs can be reversed by the contemporary administration of with adrenergic agents.
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Case Report
The experimental protocol included 15 male adult “New
Zealand white rabbits”, with a mean weight of 4.1 kg.
The surgical procedure consisted in a left antero-lateral
thoracotomy, pericardiotomy, and exposure of the anteri-
or wall of the left ventricle. The anterior descending coro-
nary artery, identified in its third proximal segment, was
occluded for a time ranging from 4 to 5 minutes, until
an area of myocardial tissue of 1-1.5 cm in diameter
appeared ischemic. At the end of the surgical procedure,
a complete re-expansion of the left lung was obtained with
the simple aid of a temporary pleural aspiration 3.
The animals were subdivided in three groups of five rab-
bits each:
– Sham;
– Intravenous injection of BM stem cells;
– Intra-myocardial injection of BMSC.  
The anesthesiological protocol included three drugs, a
benzodiazepine (Midazolam), an alpha2-adrenergic agent,
and an anaesthetic (2,6, -diisopropilfenol - Propofol),
selected for their respective action of sedation, alpha-2
mimetic activity and analgesia. The first two drugs were
Introduction 
The choice of animals for cardiovascular experimental
studies depends: first, on their physiological and anatom-
ical characteristics; then, on the size of the animal, stab-
ulation cost, human protective affection, and on anaes-
thesiological and monitoring facilities. In our experi-
mental study on cardiac ischemia/reperfusion damage and
subsequent treatment with homologous bone marrow
mesenchymal stem cells (BMSC), we selected rabbits for
their similarities with human coronary arteries and with
patho-physiology of immunological system 1,2. 
However, these animals have a particular pharmaco-anaes-
thesiology, in relation to their susceptibility to stressor agents
and to particular sensibility to some anaesthetic agents.
administered at the induction of anaesthesia, while the
third was continued throughout the entire surgery.
Animals were sedated by an intra-muscolar injection of
1 mg/kg of Midazolan, associated with Medetomidyne
1 mg/kg. A marginal auricular vein was cannulated with
a standard 22-Gauge intravenous catheter and an initial
dose of 2.5 mg/kg Propofol solution was administrated
2 minutes before surgical positioning. The depth of
anaesthesia was maintained with equivalent doses admin-
istered every 5 minutes throughout the entire surgery.
The spontaneous respiratory activity was assured with a
simple muzzle musk connected with a bag valve system
of 0.5 litre using room air, enriched with a 50% O2,
even during the one lung ventilation phase. 
The intra-operative monitoring consisted of a continu-
ous ECG recording and of a pulse oximetry. Hypotension
and blood losses were compensated by saline infusion. 
Evaluation of Side effects of anaesthesia was assessed dur-
ing and early after surgery (within the first 12 hours).
We monitored the following parameters: 
– respiratory depression, requiring manual respiratory
assistance and/or an increased oxygen supply;
– severe bradycardia or arrhythmia (recorded by ECG);
– death.
All animals received care in compliance with the
European Convention on Animal (Directive 2010/63/EU
of  22.09.2009).  
The protocol was approved by Research Animal Care
and Use Committee of the University of Modena and
Reggio Emilia (Italy) (prot. # 25, 18/03/2008 and prot.#
83, 25/ 09/2009).
Results and Discussion
We reported 3 episodes of reversible ventricular tachy-
cardia (VT) and one episode of ventricular fibrillation
successfully cardioverted during induction of ischemia.
We registered only one fatal complication (6.66%), rep-
resented by a ventricular arrhythmia developed during
intra-myocardial BMSC injection. It is well known that
the direct intramyocardial administration of BMSC can
induce a transient pro-arrhythmic effect. 4
The anaesthesiological protocol we tested demonstrated
a proper action of sedation and myo-relaxation, without
hindering the spontaneous respiration 5. The depth of
analgesia was proved by suppression of any muscular
reaction to surgical stimuli, which are potential stressors
for rabbit. Neither administration of anti-arrhythmic
drugs, such as lidocaine, nor invasive monitoring of the
arterial pressure was necessary, considering the absence
of cardio-circulatory adverse effects 6. Interestingly, this
venous anaesthesiological protocol avoided the use of
neuromuscular blocking agent 7. The correct oxygena-
tion, recorded throughout the entire surgical time and
obtained with enriched air, avoided oro-tracheal intuba-
tion, complex manoeuvre in rabbits. Moreover, the rapid
effects of Propofol allowed a quick anaesthesiological
recovery.  
In conclusion, our experience in rabbit experimental car-
diac surgery indicates Propofol as a suitable analgesic agent
for the induction of anaesthesia and its maintenance.
Propofol mild cardio-respiratory depressing action may be
effectively balanced associating an alpha2–adrenergic
agent8. 
Riassunto
PREMESSA.: La chirurgia sperimentale richiede un approc-
cio farmacologico che può interferire con la funzione car-
diaca.
METODI:In un modello animale di chirurgia rigenerativa
del miocardio abbiamo utilizzato un protocollo aneste-
siologico che includeva Propofol, una benzodiazepina
(Midazolam) e un alfa2-adrenergico.
RISULTATI:In un gruppo di 15 conigli sottoposti a chi-
rurgia cardiaca abbiamo osservato 1 complicanza aritmi-
ca letale durante la somministrazione intramiocardica di
cellule staminali.
DISCUSSIONE. L’azione di depressione della funzione car-
dio respiratoria del Propofol è stata compensate da far-
maci con attività alfa2-adrenergica che hanno ridotto
notevolmente le complicanze aritmiche. 
Ipotizziamo che l’azione di depressione della funzionalità
cardio respiratoria di farmaci anestesiologici utilizzati nel-
la chirurgia sperimentale cardiaca nel coniglio possa esse-
re controllata dalla somministrazione contemporanea di
agenti adrenergici.
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